loader
Please Wait
Applying Filters...

Seqens Seqens

X

Looking for DSSTox_CID_3177? Find Controlled & Modified Release used in DSSTox_CID_3177 to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Gangwal Healthcare (2)

02 BASF (16)

03 Kerry (1)

filter

01 Capsule (5)

02 Granule / Pellet (1)

03 Softgel Capsule (1)

04 Tablet (6)

05 Topical Film (2)

06 Transdermal Patch (3)

07 Transdermal patches (1)

filter

01 Germany (16)

02 India (2)

03 U.S.A (1)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Immediate Release

Ingredient(s): Glycerol, Unmodified, Hydroxypropyl Methylcellulose

Dosage Form: Tablet

Category: Coating Systems & Additives, Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Customized per requirements

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

Ingredient(s): Polyvinyl Acetate, Sodium Lauryl Sulfate

Dosage Form: Capsule, Granule / Pellet, Softgel Capsule, Tablet, Topical Film

Category: Coating Systems & Additives, Controlled & Modified Release, Taste Masking

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying

Ingredient(s): Povidone

Dosage Form: Capsule, Tablet, Transdermal Patch

Category: Controlled & Modified Release

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY